Evidence map›Paper›PMID 36584414›Full record

ArticleJournal of behavior therapy and experimental psychiatry2023

Development and preliminary validation of the treatment adherence rating scale.

Nicole B Gumport, Lu Dong, Jason Y Lee, Xin Zhao, Allison G Harvey

Open access · greenAbstract read
In one paragraph

Article in Journal of behavior therapy and experimental psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Do improved patient recall and the provision of memory support enhance treatment adherence?Journal of behavior therapy and experimental psychiatry · 2017
    Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Nicole B GumportStanford University School of Medicine, USA. Electronic address: ngumport@stanford.edu.
Lu DongRAND Corporation, USA. Electronic address: ldong@rand.org.
Jason Y LeeUniversity of California, Berkeley, USA. Electronic address: jaylee24@gmail.com.
Xin ZhaoUniversity of California, Berkeley, USA. Electronic address: xzhao022@fiu.edu.
Allison G HarveyUniversity of California, Berkeley, USA. Electronic address: aharvey@berkeley.edu.
University of California, Berkeley · USRAND Corporation · USStanford University · US

Funding

A BIOBEHAVIORAL RESEARCH TRAINING PROGRAMT32MH019938 · NIMH · STANFORD UNIVERSITY · PI Corey J Keller, RACHEL MANBER · 1994 to 2026
$9.4M
Triple Vulnerability? Circadian Tendency, Sleep Deprivation and AdolescenceR01HD071065 · NICHD · UNIVERSITY OF CALIFORNIA BERKELEY · PI HARVEY, ALLISON G · 2012 to 2025
$6.4M
Improving Depression Outcome by Enhancing Memory for Cognitive TherapyR34MH094535 · NIMH · UNIVERSITY OF CALIFORNIA BERKELEY · PI HARVEY, ALLISON G · 2012 to 2014
$813k
NICHD NIH HHS R01 HD071065NIMH NIH HHS R34 MH094535NIMH NIH HHS T32 MH019938
6 · The paper itself

Abstract

BACKGROUND AND

objectivesPatient adherence to treatment is an important barrier to the implementation of evidence-based psychological treatments (EBPTs). There is a need for simple and deployable measures of patient adherence to treatment for use across EBPTs. The Treatment Adherence Rating Scale (TARS) was developed and validated in two samples.

methodsThis study includes two samples: adults with Major Depressive Disorder who received Cognitive Therapy for depression (Sample 1; N = 48, mean age = 44.27 years), and at-risk adolescents who received either the Transdiagnostic Sleep and Circadian Intervention or Psychoeducation (Sample 2; N = 176, mean age = 14.77 years). Factor structure of the TARS scores was examined via Exploratory Factor Analyses (EFA) in Sample 1 and Confirmatory Factor Analyses (CFA) in Sample 2. Internal consistency, predictive validity, and construct validity of the TARS scores were examined.

resultsResults from EFA in Sample 1 supported a one-factor model. Results from CFA in Sample 2 suggested that a two-factor model (i.e., agreement and compliance) fit better than a one-factor model. TARS scores from both samples demonstrated adequate predictive validity with primary clinical outcomes and construct validity with treatment expectations. LIMITATIONS: The sample was small with two specific populations. Future research should focus on other patient populations, a larger population, and other EBPTs. Future research examining patient ratings of these items are needed for further validation of the TARS.

conclusionsPreliminary findings support the use of a two-factor model and highlight the potential utility of a simple measure of patient adherence to treatment across age and diagnostic groups.

Indexed as

Major Depressive DisorderAdolescentAdultFactor Analysis, StatisticalHumansPsychometricsReproducibility of ResultsSleepSurveys and QuestionnairesTreatment Adherence and ComplianceCognitive therapyDepressionFactor analysisScale developmentSleepTreatment adherence

Identifiers

PMID36584414
PMCPMC10013098
OpenAlexW4312221306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.